Nicotine / THR - Statements from Experts: Difference between revisions

Jump to navigation Jump to search
Line 1,666: Line 1,666:
<br>
<br>
[[file:US Mitch Zeller JD.png|center]]
[[file:US Mitch Zeller JD.png|center]]
<br>
===Thomas Brandon, PhD, United States===
[[File:Thomas_Brandon_PhD.jpg|thumb|left|Moffitt Cancer Center]]<br>
Earlier this year, the findings from a major clinical trial, published in the New England Journal of Medicine, showed that e-cigarettes were almost twice as effective as the nicotine patch for producing one year of smoking cessation. These findings added to those of other, smaller studies previously published. 
“[https://moffitt.org/newsroom/press-release-archive/2019/moffitt-cancer-center-studies-how-e-cigarettes-help-smokers-quit/ This could be a game-changer for lots of people,” says Thomas Brandon, Ph.D]., director of Moffitt’s Tobacco Research and Intervention Program and chair of the Department of Health Outcomes and Behavior. “It means that for smokers who have not been able to quit by using the available medications, vaping might be worth a try. But it is important to completely switch from smoking to vaping to get the most health benefits.”
[https://moffitt.org/research-science/research-teams/tobacco-research-and-intervention-program-trip/meet-the-trip-team/#:~:text=Thomas%20Brandon%2C%20PhD%2C%20is%20the,Behavior%20at%20Moffitt%20Cancer%20Center.&text=With%20interventions%2C%20he%20has%20concentrated,treatments%20and%20self%2Dhelp%20interventions. Thomas Brandon, PhD, is the Director of the Tobacco Research and Intervention Program] and Chair of the Department of Health Outcomes and Behavior at Moffitt Cancer Center.  He is also Professor of Psychology and Oncologic Sciences at the University of South Florida
[https://twitter.com/Vapingit/status/1454534518824636418/photo/1 SEE: Tweet w/graphic]
<br>
<br>
<br>
<br>